| | FARS2, LOC126859565 (R104S) | Single nucleotide variant (missense variant +1 more) | Inborn genetic diseases | |
| | | Duplication | Combined oxidative phosphorylation defect type 14 | |
| | | Deletion | Combined oxidative phosphorylation defect type 14 | |
| | | Deletion | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC129995672 +1 more (K21N) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | FARS2, LOC126859565 (P132L) | Single nucleotide variant (missense variant +1 more) | Inborn genetic diseases | |
| | FARS2, LOC126859565 (T121K) | Single nucleotide variant (missense variant +1 more) | Inborn genetic diseases | |
| | FARS2, LOC126859565 (R148W) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (H159Y) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (nonsense +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Deletion | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided | |
| | FARS2, LOC126859565 (A170V) | Single nucleotide variant (missense variant +1 more) | FARS2-related disorder | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | FARS2, LOC126859565 (H63N) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | FARS2, LOC129995672 +1 more (R14W) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | FARS2, LOC129995672 +1 more (L12V) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | FARS2, LOC126859565 (E95G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (W87C) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (M151I) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC129995672 +1 more | Single nucleotide variant (synonymous variant +1 more) | not provided | |
| | FARS2, LOC126859565 (Q60*) | Single nucleotide variant (nonsense +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (L168fs) | Duplication (frameshift variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (L130F) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (V51L) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (L130R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (T149S) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (R104H) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A170T) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (G106V) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A42V) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A38E) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (K69R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Deletion (intron variant) | Schizophrenia | |
| | FARS2, LOC126859565 (K99R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | LOC126859565, FARS2 (N147K) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC129995672 +1 more (Y13fs) | Deletion (frameshift variant +1 more) | not provided | |
| | FARS2, LOC126859565 (D142N) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (G75V) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (H29R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (V197M) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 +1 more | GConflicting classifications of pathogenicity |
| | FARS2, LOC126859565 (D62Y) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (W87G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (K99N) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC129995672 +1 more (A3V) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | FARS2, LOC126859565 (A31T) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (D142G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (P136L) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (S49N) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (S137G) | Single nucleotide variant (missense variant +1 more) | Inborn genetic diseases +1 more | |
| | FARS2, LOC126859565 (L172P) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 +1 more | |
| | FARS2, LOC126859565 (S128G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (R198W) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (R180H) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC129995672 +1 more (A7T) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | FARS2, LOC126859565 (R148Q) | Single nucleotide variant (missense variant +1 more) | not provided +1 more | |
| | FARS2, LOC126859565 (Y188H) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (Q44R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (G103A) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (D142fs) | Deletion (frameshift variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A10T) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (W32R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |